Feedback (LON:FDBK) Stock Passes Above 50 Day Moving Average – What’s Next?

Feedback plc (LON:FDBK)’s share price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 10.29 and traded as high as GBX 11.15. Feedback shares last traded at GBX 11, with a volume of 138,000 shares.

Feedback Stock Performance

The company has a market cap of £4.82 million, a price-to-earnings ratio of -0.43 and a beta of 0.77. The business has a fifty day moving average price of GBX 10.29 and a two-hundred day moving average price of GBX 10.76.

Insiders Place Their Bets

In other news, insider Emma Oswick (Stuart) purchased 60,459 shares of the stock in a transaction that occurred on Tuesday, December 23rd. The shares were purchased at an average cost of GBX 8 per share, for a total transaction of £4,836.72. Also, insider Tom Oakley bought 60,904 shares of Feedback stock in a transaction that occurred on Tuesday, December 23rd. The stock was purchased at an average cost of GBX 8 per share, with a total value of £4,872.32. 7.98% of the stock is currently owned by insiders.

About Feedback

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.